Program
13-valent pneumococcal vaccine
Also written as “13-valent pneumococcal conjugate vaccine”, “13-valent Pneumococcal Conjugate Vaccine” and “13vPnC”.
Its studies are mostly in Pneumococcal Infections · Pneumonia, Pneumococcal · Pneumonia · Influenza, Human · HIV Infections, led by 7 companies.
Drug page13-valent pneumococcal vaccine: every studyMany companies study it; this page follows only the 65 they lead. All 129 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pfizer | 570 open or running | phase 4since Aug 27, 2008 | Sep 19, 2005 | none ahead |
| CanSino Biologicsits history only | 31 open or running | phase 3since Apr 8, 2021 | Sep 18, 2019 | Feb 15, 2027phase 3 · NCT07017777 |
| Beijing Minhai Biotechnologyits history only | 10 open or running | phase 4since Jan 8, 2024 | Jan 8, 2024 | none ahead |
| Fosun Pharmaits history only | 11 open or running | phase 3since Feb 26, 2023 | Feb 26, 2023 | none ahead |
| Sinovac Biotechits history only | 10 open or running | phase 1since Oct 13, 2021 | Oct 13, 2021 | none ahead |
| Walvax Biotechnologyits history only | 10 open or running | phase 3since Mar 31, 2016 | Mar 31, 2016 | none ahead |
| Wuhan BravoVaxits history only | 10 open or running | phase 1since Oct 24, 2022 | Oct 24, 2022 | none ahead |
Also a collaborator on its studies: Liaoning Chengda Biotechnology.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Pfizer only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 43 studies since Sep 19, 2005.
- Aug 12, 2011Phase 1 study in Pneumococcal InfectionsNCT01531322 · 72 enrolled · China
- May 10, 2012Phase 3 study in Pneumococcal VaccinesNCT01646398 · 764 enrolled · Japan
- Jul 11, 2012Phase 3 study in Pneumococcal InfectionsNCT01692886 · 1,674 enrolled · China
- Sep 9, 2013Phase 3 study in Pneumococcal VaccinesNCT01964716 · 500 enrolled · Gambia
- Jan 10, 2014Phase 4 study in Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnCNCT02034877 · 1,200 enrolled · India
- Apr 24, 2014Phase 4 study in Influenza, HumanNCT02124161 · 882 enrolled · United States
- May 22, 2018Phase 3 study in Pneumococcal InfectionsNCT03574389 · 936 enrolled · China
- May 22, 2018Phase 4 study in VaccinesNCT03548337 · 301 enrolled · India
- May 25, 2018Phase 2 study in Pneumococcal InfectionsNCT03550313 · 565 enrolled · United States
- Jun 20, 2018Phase 3 study in Pneumococcal InfectionsNCT03571607 · 206 enrolled · Japan
- Dec 4, 2018Phase 4 study in VaccinesNCT03777865 · 100 enrolled · India
- Mar 29, 2022No phase study in Immunogenicity, VaccineNCT05372575 · 300 enrolled · China
- Apr 7, 2022Phase 4 study in Pneumococcal InfectionsNCT05329259 · 200 enrolled · India
- Jun 5, 2025Phase 1 study in Pneumococcal InfectionsNCT07019909 · 400 enrolled · China
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“A pneumococcal conjugate vaccine containing 13 different strains of the bacterium Streptococcus pneumoniae, used in children and studied in immunocompromised patients for the prevention of pneumococcal disease”NCIt, by rule
Studies
All 57 Pfizer leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07019909Pneumococcal Infections · China | 1 | Completed | Jan 28, 2026 | 400 |
| NCT05329259Pneumococcal Infections · India | 4 | Completed | Nov 30, 2022 | 200 |
| NCT05372575Immunogenicity, Vaccine · China | – | Completed | Dec 14, 2021 | 300 |
| NCT03777865Vaccines · India | 4 | Completed | Apr 17, 2019 | 100 |
| NCT03571607Pneumococcal Infections · Japan | 3 | Completed | Nov 16, 2018 | 206 |
| NCT03550313Pneumococcal Infections · United States | 2 | Terminated | Nov 5, 2020 | 565 |
| NCT03574389Pneumococcal Infections · China | 3 | Completed | Aug 23, 2021 | 936 |
| NCT03548337Vaccines · India | 4 | Completed | Dec 20, 2019 | 301 |
| NCT02124161Influenza, Human · United States | 4 | Completed | May 2015 | 882 |
| NCT02034877Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC · India | 4 | Completed | Jul 2015 | 1,200 |
| NCT01964716Pneumococcal Vaccines · Gambia | 3 | Completed | Sep 2014 | 500 |
| NCT01692886Pneumococcal Infections · China | 3 | Completed | Apr 2014 | 1,674 |
| NCT01646398Pneumococcal Vaccines · Japan | 3 | Completed | Oct 2012 | 764 |
| NCT01531322Pneumococcal Infections · China | 1 | Completed | Jan 2012 | 72 |
| NCT01392378Pneumococcal Vaccines · Poland | 4 | Completed | Jan 2013 | 908 |
| NCT01432262Pneumococcal Infections · Mexico | 3 | Completed | Dec 2011 | 324 |
| NCT01200368Healthy Subjects · Japan | 3 | Completed | Nov 30, 2011 | 551 |
| NCT01193335Premature Birth · Poland, Spain | 4 | Completed | Jan 2014 | 200 |
| NCT0102603813-valent Pneumococcal Vaccine · France | 3 | Completed | Nov 2010 | 263 |
| NCT00980655Vaccines, Pneumococcal Conjugate Vaccine · United States, Belgium, Canada and more | 3 | Completed | May 16, 2013 | 251 |
| NCT00963235HIV Infections · United States | 3 | Completed | May 2012 | 331 |
| NCT00962780HIV Infections · Romania, South Africa | 3 | Completed | Apr 2013 | 303 |
| NCT00918580Pneumococcal Conjugate Vaccine · United States, Egypt, France and more | 3 | Completed | Mar 2013 | 158 |
| NCT00853749Invasive Pneumococcal Disease · Iceland | 3 | Completed | Dec 16, 2009 | 89 |
| NCT00824850Pneumococcal Conjugate Vaccine · United States | 2 | Completed | Sep 2010 | 75 |
| NCT00824655Pneumococcal Vaccines · Sweden | 3 | Completed | Jun 2010 | 234 |
| NCT00761631Healthy Subjects · United States | 3 | Completed | Aug 10, 2010 | 1,200 |
| NCT00744263Pneumonia, Pneumococcal · Netherlands | 4 | Completed | Oct 2013 | 84,496 |
| NCT00743652Pneumococcal Infections · United States | 3 | Completed | Sep 2010 | 373 |
| NCT00708682Vaccines, Pneumococcal · Mexico | 3 | Completed | May 2010 | 225 |
| NCT00689351Disease · Korea, Republic of | 2 | Completed | Dec 2009 | 180 |
| NCT00688870Vaccines · Taiwan | 3 | Completed | Jan 13, 2010 | 168 |
| NCT00676091Vaccines, Pneumococcal Conjugate Vaccine · Brazil | 3 | Completed | Sep 2009 | 354 |
| NCT00574795Vaccines, Pneumococcal Conjugate Vaccine · Japan | 3 | Completed | Aug 2008 | 193 |
| NCT00574548Pneumococcal Vaccines · United States | 3 | Completed | Feb 2010 | 720 |
| NCT00562354Healthy · Japan | 3 | Completed | Dec 2007 | 271 |
| NCT00546572Pneumococcal Infections · United States, Sweden | 3 | Completed | Jul 2010 | 938 |
| NCT00521586Influenza, Human · United States | 3 | Completed | Dec 2013 | 1,116 |
| NCT00508742Pneumococcal Infections · Israel | 3 | Completed | Aug 2011 | 1,866 |
| NCT00500357Vaccines, Pneumococcal Conjugate Vaccine · South Africa | 3 | Completed | Jan 2010 | 105 |
| NCT00500266Pneumococcal Infections · United States, Germany, Sweden | 3 | Completed | Apr 2009 | 1,053 |
| NCT00492557Pneumococcal Infections | 3 | Completed | Feb 2008 | 1,185 |
| NCT00475033Vaccines, Pneumococcal Conjugate Vaccine · Canada | 3 | Completed | May 2009 | 603 |
| NCT00474539Vaccines, Pneumococcal · Spain | 3 | Completed | Mar 2009 | 449 |
| NCT00464945Pneumococcal Vaccines · Poland | 3 | Completed | Sep 2008 | 269 |
| NCT00452790Pneumococcal Infections · India | 3 | Completed | Oct 2009 | 708 |
| NCT00452452Pneumococcal Infections · Poland | 3 | Completed | Mar 2008 | 355 |
| NCT00444457Vaccines, Pneumococcal · United States | 3 | Completed | Jun 2009 | 1,712 |
| NCT00427895Pneumococcal Infections · United States | 3 | Completed | Aug 1, 2011 | 2,141 |
| NCT00384059Vaccines, Pneumococcal · United Kingdom | 3 | Completed | Oct 2008 | 286 |
| NCT00373958Vaccines, Pneumococcal · United States | 3 | Completed | Jun 2008 | 666 |
| NCT00368966Vaccines, Pneumococcal · Spain | 3 | Completed | Jul 2008 | 619 |
| NCT00366899Vaccines, Pneumococcal · Italy | 3 | Completed | Jul 2008 | 605 |
| NCT00366678Vaccines, Pneumococcal · France | 3 | Completed | Nov 2008 | 613 |
| NCT00366340Vaccines, Pneumococcal · Germany | 3 | Completed | Aug 2008 | 604 |
| NCT00269672Vaccines, Pneumococcal Conjugate Vaccine | 2 | Completed | Feb 2007 | 915 |
| NCT00205803Pneumococcal Infections · United States | 2 | Completed | 249 |
How it is read
Names in the registry
- “13-valent pneumococcal conjugate vaccine”, 23 entries
- “13-valent Pneumococcal Conjugate Vaccine”, 20 entries
- “13vPnC”, 9 entries
- “13-valent pneumococcal conjugate vaccine (13vPnC)”, 8 entries
- “PCV13”, 5 entries
Codes read as this program: PCV13I.
Conditions, from the studies’ own filings
- Pneumococcal Infections, 26 studies
- Pneumonia, Pneumococcal, 2 studies
- Pneumonia, 2 studies
- Influenza, Human, 2 studies
- HIV Infections, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.